CYTK
Cytokinetics Incorporated
$61.03
+$1.44(+2.42%)
54
Overall
40
Value
75
Tech
47
Quality
Market Cap
$5.82B
Volume
2.17M
52W Range
$29.31 - $61.48
Target Price
$75.95
EPS Estimates Overview
| Current Quarter | $-1.59 | Next Quarter | $-1.62 |
| Current Year | $-5.65 | Next Year | $-5.83 |
| QoQ Growth | -1.9% | YoY Growth | -3.2% |
| 3Y EPS CAGR | -23.4% | Target Price | $75.95 |
| Consensus | Buy | Upside | +24.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CYTK | $61.03 | +2.4% | 2.17M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cytokinetics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW